Landos Biopharma, Inc. Profile Avatar - Palmy Investing

Landos Biopharma, Inc.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic c…

Biotechnology
US, Blacksburg [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Landos Biopharma, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Landos Biopharma, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Landos Biopharma, Inc..

End of LABP's Analysis
CIK: 1785345 CUSIP: 515069102 ISIN: US5150692011 LEI: - UEI: -
Secondary Listings
LABP has no secondary listings inside our databases.